QR-Code

Quantification of bactericidal activity using the PATHFAST TB LAM Ag assay during the first 14 days of pulmonary tuberculosis treatment

BackgroundTuberculosis (TB) remains a global health challenge. Culture-free, rapid, and quantitative biomarkers to monitor treatment response are critical to accelerate development of better TB treatments. The PATHFAST TB LAM Ag assay (PATHFAST-LAM), a desktop chemiluminescent enzyme immunoassay tha...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Ayumi Akinaga, Andreas H. Diacon, Remous Ocloo, Atsushi Yanagida, Naofumi Yoda, Masanori Kawasaki, Yongge Liu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2025-05-01
Schriftenreihe:Frontiers in Antibiotics
Schlagworte:
tuberculosis
treatment monitoring
lipoarabinomannan
biomarker
bacterial load
immunoassay
Online-Zugang:https://www.frontiersin.org/articles/10.3389/frabi.2025.1574688/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge